Blood Analyzers in Nevada

Entegrion, Inc. is a life sciences company specializing in viscoelastic coagulation monitoring (VCM) systems for rapid hemostasis assessment. The company develops point-of-care diagnostic instruments designed to measure blood coagulation in real-time, enabling clinicians to manage hemostasis and coagulopathies across trauma, surgery, obstetrics, and emergency medicine settings. The VCM system uses fully automated testing with fresh whole blood—no chemical accelerants or sample manipulation required—making it suitable for bedside and pre-hospital applications. The device features a portable footprint optimized for multiple clinical environments. Entegrion's products address both civilian and military medicine needs; the U.S. Department of Defense has invested over $100 million in the company's product development since inception. The VCM has achieved CE Mark regulatory clearance in Europe and other regions accepting CE-marked devices; however, it has not yet received FDA 510(k) clearance for human clinical use in the United States. The company also offers VCMVet for veterinary coagulation monitoring and VCM Cascade for human applications. Leadership includes experienced healthcare executives and clinicians with backgrounds in emergency medicine, hematology, laboratory diagnostics, and transfusion medicine. The organization combines R&D, clinical validation, and regulatory expertise to bring complex laboratory tests to point-of-care settings.

Newmarket Biomedical Ltd is a British in-vitro diagnostic (IVD) reagents and test kits manufacturer established in 2011. The company specializes in the worldwide manufacture, sale, and distribution of diagnostic kits and laboratory products, with particular expertise in syphilis serology testing. Core product lines include RPR (rapid non-treponemal particle agglutination) tests, TPHA (passive particle agglutination assays for Treponema pallidum detection), Syphilis EIA Total Antibody tests, and bulk reagents available upon request. Newmarket Biomedical holds ISO 13485 and MDSAP certifications, with QMS recertification valid until 2027. The company is IVDR-compliant for TPHA and RPR kits, demonstrating adherence to EU in-vitro diagnostic regulations. Products are distributed globally across the UK, USA, Canada, EU, India, Australia, Vietnam, Philippines, South Africa, and other territories. The company maintains quality assurance and regulatory compliance standards suitable for clinical laboratory, research, and diagnostic applications.